BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Other News

Biogen Idec, GlaxoSmithKline, Roche cancer news

Biogen Idec and Roche's Genentech Inc. unit appealed a district's court ruling in favor of GlaxoSmithKline in a patent infringement suit related to rival therapies for chronic lymphocytic leukemia (CLL). The appeal was filed in the U.S. Court of Appeals for...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >